News
GlaxoSmithKline has claimed victory in its controversial bid to block parallel imports of its drugs from Canada into the US.
Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong Swiss franc undercutting sales...
The UK patent system is damaging scientific research and creating a old rush mentality according to the Royal Society.
The Government's political gamble on improving the NHS could fail because of shortcomings in its huge investment and reform programme, according to a...
The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against premature hopes for medical...
Abbott Labs recorded a 6% drop in profits for the first quarter of 2003 following heavy spending on the launch of its new arthritis drug Humira.
The new head of the Commission for Healthcare Audit and Inspection has resigned just weeks after being appointed, following a personality clash with...
GlaxoSmithKline has suffered a set back in its bid to see off early US generic competition for antibiotic Augmentin, one of its biggest products.
European MPs have voted to ban the use of human cloning and embryonic stem cells for research purposes.